MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome. (2018)

First Author: Bayley R
Attributed to:  The role of MYBL2 in the age-related development of blood disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.26477

PubMed Identifier: 30680058

Publication URI: http://europepmc.org/abstract/MED/30680058

Type: Journal Article/Review

Volume: 9

Parent Publication: Oncotarget

Issue: 101

ISSN: 1949-2553